Mesenchymal stem cells in health and disease
… (straight, solid arrows) towards the mesodermal lineage. The … for the first time to treat children
with severe osteogenesis … issues will allow for the translation of our basic knowledge of …
with severe osteogenesis … issues will allow for the translation of our basic knowledge of …
Off-the-shelf tissue-engineered vascular conduits: clinical translation
ES Fioretta, L von Boehmer, M Generali… - Tissue-Engineered …, 2020 - Springer
… cell sources – including induced pluripotent stem cells – and … used for the treatment of CHD
is polytetrafluoroethylene (… stem cells that could differentiate towards multiple cell phenotypes …
is polytetrafluoroethylene (… stem cells that could differentiate towards multiple cell phenotypes …
Cell therapy for the treatment of coronary heart disease: a critical appraisal
KC Wollert, H Drexler - Nature Reviews Cardiology, 2010 - nature.com
… , stem cell therapy instead of bone marrow cell (BMC) therapy, … A trend towards a greater
incidence of arrhythmias was, … Translation of these concepts from disease models into the …
incidence of arrhythmias was, … Translation of these concepts from disease models into the …
Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary‐induced obesity
… Translating the ability of LMMS to bias bone formation over fat … for fractures in normally active
children and adolescents, it … a distinct bias toward osteogenesis after 6 wk, translating at 12 …
children and adolescents, it … a distinct bias toward osteogenesis after 6 wk, translating at 12 …
Spotlight on HDL biology: new insights in metabolism, function, and translation
DJ Rader - Cardiovascular Research, 2014 - academic.oup.com
… not been shown to be protective against CHD. However, because … men with CHD treatment
with immediate-release niacin … For example, cholesterol efflux from hematopoietic stem cells …
with immediate-release niacin … For example, cholesterol efflux from hematopoietic stem cells …
Efficient derivation of human cardiac precursors and cardiomyocytes from pluripotent human embryonic stem cells with small molecule induction
XH Parsons, YD Teng, JF Parsons, EY Snyder… - JoVE (Journal of …, 2011 - jove.com
… pluripotent stem cells towards specialized functional cells. (A) … developmental study and
clinical translation has been how … associated with human congenital heart disease (CHD), the …
clinical translation has been how … associated with human congenital heart disease (CHD), the …
A strong regenerative ability of cardiac stem cells derived from neonatal hearts
… address the structural deficiencies of congenital heart disease. … Differentiation of CDCs toward
cardiac lineages was … augmentation of proangiogenic factors translated to increase blood …
cardiac lineages was … augmentation of proangiogenic factors translated to increase blood …
[HTML][HTML] Biological scaffolds for congenital heart disease
AG Harris, T Salih, MT Ghorbel, M Caputo, G Biglino… - Bioengineering, 2023 - mdpi.com
… , most of them failed to be successfully translated in this life-… in paediatric CHD treatment,
warning against the application … primary cell types have a limited lifespan, stem cells are self-…
warning against the application … primary cell types have a limited lifespan, stem cells are self-…
[HTML][HTML] Drug and cell delivery for cardiac regeneration
CL Hastings, ET Roche, E Ruiz-Hernandez… - Advanced drug delivery …, 2015 - Elsevier
… in the treatment of cardiovascular disease. The most effective … However, clinical translation
of regenerative therapeutics … trials, cardiac stem cells, or cardiopoietic stem cells have shown …
of regenerative therapeutics … trials, cardiac stem cells, or cardiopoietic stem cells have shown …
[PDF][PDF] Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cells
L Jin, EM Lee, HS Ramshaw, SJ Busfield, AG Peoppl… - Cell stem cell, 2009 - cell.com
… isolated AML CD34+ CD38À cells in vitro and reduced … therapeutic monoclonal antibody
(mAb) targeting of AML-LSCs and for translation of in vivo preclinical research findings toward a …
(mAb) targeting of AML-LSCs and for translation of in vivo preclinical research findings toward a …